Phase I Trial and Preclinical Data of ACT Using Neoantigen-Reactive TIL for Patients with Advanced Epithelial and ICB-resistant Solid Cancers
Immuno-Oncology and Technology(2024)
AI 理解论文
溯源树
样例

生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要
Immuno-Oncology and Technology(2024)